Safety and Activity of Revumenib in Combination With Fludarabine/Cytarabine (FLA) in Patients With Relapsed/Refractory Acute Leukemias

Abstract | Jun 13, 2024

Author

Shukla N, et al.

Congress

European Hematology Association Annual Congress

Madrid, Spain | June 13 – 16, 2024